•
Jun 30, 2013

PTC Therapeutics Q2 2013 Earnings Report

Total Revenue
$5.87M
Previous year: $6.06M
-3.2%
EPS
$6.49K
Previous year: $6.13K
+6.0%
Cash and Equivalents
$154M
Previous year: $22.2M
+592.6%
Total Assets
$175M

PTC Therapeutics

PTC Therapeutics